Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance

Diabetes Research and Clinical Practice

Volumn 69, Issue 3, 2005, Pages 305-308

  Arii, Kaoru ^a   Ota, Kikuko ^a   Suehiro, Tadashi ^a   Ikeda, Yukio ^a   Nishimura, Kanae ^a   Kumon, Yoshitaka ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

IGT; Insulin resistance; Pioglitazone; Reactive hypoglycemia; Thiazolidine

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; PIOGLITAZONE;

ADULT; ARTICLE; CASE REPORT; DIET THERAPY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; ORAL GLUCOSE TOLERANCE TEST;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; THIAZOLIDINEDIONES;

EID: 23744493935     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.01.004     Document Type: Article

References (18)

1. A. Lev-Ran, and R.W. Anderson The diagnosis of postprandial hypoglycemia Diabetes 30 1981 996 999
2. E. Renald, C. Paper-Richard, J.L. Richard, S. Juredini, A. Orsetti, and J. Mirouze Effect of miglitol (Bay m1099), a new α-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms Diabet. Metab. 17 1991 355 362
3. A.G. Ozgen, F. Hamulu, and F. Bayraktar Long-term treatment with acarbose for the treatment of reactive hypoglycemia Eat Weight Dis. 3 1998 136 140
4. S. Teno, Y. Nakajima-Uto, and K. Nagai Treatment with alpha-glucosidase inhibitor for severe reactive hypoglycemia: a case report Endocr. J. 47 2000 437 442
5. G. Tamburrano, F. Leonetti, P. Sbraccia, A. Giaccari, N. Locuratolo, and A. Lala Increased insulin sensitivity in patients with idiopathic reactive hypoglycemia J. Clin. Endocrinol. Metab. 69 1989 885 890
6. J.W. Conn, S.S. Fajans, and H.S. Seltzer Spontaneous hypoglycemia as an early manifestation of diabetes mellitus Diabetes 5 1956 437 442
7. D. Porte Jr Banting lecture. Beta-cells in type II diabetes mellitus Diabetes 40 1991 166 180
8. M.J. Perley, and D.M. Kipnis Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects J. Clin. Invest. 46 1967 1954 1962
9. M.A. Permutt, J. Kelly, R. Bernstein, D.H. Alpers, B.A. Siegel, and D.M. Kipnis Alimentary hypoglycemia in the absence of gastrointestinal surgery N. Engl. J. Med. 288 1973 1206 1210
10. M. Sekso, M. Solter, V. Zjacic, and T. Cabrijan Treatment of reactive hypoglycemia with buformin Am. J. Clin. Nutr. 28 1975 1271 1275
11. M. Uusitupa, A. Louheranta, and J. Lindstrom The Finnish fiabetes prevention study Br. J. Nutr. 83 Suppl. 1 2000 137 142
12. K.F. Eriksson, and F. Lindgarde Prevention of type 2 (non-insulin- dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study Diabetologia 34 1991 891 898
13. X.R. Pan, W.Y. Yang, G.W. Li, and J. Liu Prevalence of diabetes and its risk factors in China, 1994. National diabetes prevention and control cooperative group Diabet. Care 20 1997 1664 1669
14. J. Tuomilehto, J. Lindstrom, and J.G. Eriksson Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N. Engl. J. Med. 344 2001 1343 1350
15. J. Eriksson, J. Lindstrom, and T. Valle Prevention of Type II diabetes in subjects with impaired glucose tolerance: the diabetes prevention study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme Diabetologia 42 1999 793 801
16. J.L. Chiasson, R.G. Josse, and R. Gomis STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial Lancet 359 2002 2072 2077
17. J.J. Nolan, B. Ludvik, P. Beerdsen, M. Joyce, and J. Olefsky Improvement in glucose tolerance and insulin resistance in obese subjects treated with toroglitazone N. Engl. J. Med. 331 1994 1188 1193
18. T. Antonucci, R. Whitcomb, R. McLain, D. Lockwood, and R.M. Norris Impaired glucose tolerance is normalized by treatment with the thiazolidinedione toroglitazone Diabet. Care 20 1997 188 193